Acutaas Chemicals Limited (BOM:543349)
3,172.45
+16.70 (0.53%)
At close: Oct 7, 2026
Acutaas Chemicals Market Cap
Acutaas Chemicals has a market cap or net worth of 259.81 billion as of October 7, 2026. Its market cap has increased by 126.12% in one year.
Market Cap
259.81B
Enterprise Value
258.49B
Revenue
14.62B
Ranking
n/a
PE Ratio
66.92
Stock Price
3,172.45
ChartMarket Cap Chart
Since September 14, 2021, Acutaas Chemicals's market cap has increased from 34.07B to 259.81B, an increase of 662.61%. That is a compound annual growth rate of 49.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 259.88B | 86.18% |
| Dec 31, 2025 | 139.58B | 58.68% |
| Dec 31, 2024 | 87.96B | 112.57% |
| Dec 29, 2023 | 41.38B | 17.64% |
| Dec 30, 2022 | 35.17B | -9.65% |
| Dec 31, 2021 | 38.93B | 14.27% |
| Sep 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 275.80B |
| Shilpa Medicare | 208.03B |
| Suven Life Sciences | 87.17B |
| Symbiotec Pharmalab | 76.98B |
| IOL Chemicals and Pharmaceuticals | 61.48B |
| Gujarat Themis Biosyn | 49.76B |
| NGL Fine-Chem | 18.07B |
| Bajaj HealthCare | 10.89B |